RxDoctor Payments Data

Sara Atkinson

Family · Bridgeton, MONPI 1316508054

Payments from drug & device makers

$2,200in general payments, 2019–2025

Across 134 payments — averaging $16.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$195
  • Sanofi$125
  • Stryker$83
  • Lilly USA, LLC$30
  • Medtronic$28
  • plus $25 from 1 others

What the payments were for

  • Food & beverage$2,200100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)125$1,714
AstraZeneca(2 entities)2$195
Sanofi1$125
Stryker1$83
Lilly USA, LLC2$30
Medtronic2$28
Biohaven Pharmaceutical Holding Company Ltd.1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,200 in reported general payments places this provider in the 80th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$4,572
Medicare patients
47
Services billed
53

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban28$17,699
ClopidogrelClopidogrel Bisulfate84$374
Atorvastatin Calcium84$313
Levetiracetam16$298
Rosuvastatin Calcium14$79
Lisinopril16$72
Losartan Potassium17$50

Paid to pharmacies, not to this prescriber.

Other family in Bridgeton

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →